Latest Chronic kidney disease Stories
MARKHAM, ON, Feb. 29, 2012 /PRNewswire/ - Cytochroma today announced that Dr. Charles W. Bishop, Cytochroma's President and Chief Executive Officer, will present a corporate overview at the Cowen and Company 32(nd) Annual Health Care Conference. This presentation is scheduled at 2:00 PM ET on Monday, March 5, 2012 at the Boston Marriott Copley Place. About Cytochroma Cytochroma is a clinical stage specialty pharmaceutical company focused on developing and commercializing...
DETROIT, Feb. 28, 2012 /PRNewswire-USNewswire/ -- Ora's Alliance, benefiting the American Kidney Fund, is proud to present "Life Is What You Make It: A Concert and Conversation with Peter Buffett" at the Max M. Fisher Music Center Orchestra Hall, home of the Detroit Symphony Orchestra. The Emmy Award-winning composer, best-selling author, and philanthropist's program combines multimedia and personal stories with a cello-accompanied live piano/vocal performance, to give the...
HOUSTON, Feb. 25, 2012 /PRNewswire/ -- Physicians, researchers and a nurse from the Renal Center at Texas Children's Hospital in Houston received prominent acclaim during the 32nd( )Annual Conference on Dialysis (ADC) held Feb. 26 through 28, in San Antonio, Texas. The conference, sponsored by the University of Missouri-Columbia, convened an international group of thousands of practitioners and researchers to discuss current developments in the field of renal replacement therapies....
LAWRENCE, Mass. and SAN ANTONIO, Feb. 24, 2012 /PRNewswire/ -- ADC 2012 Booth B -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it is participating in several industry-focused educational presentations on more frequent home hemodialysis with the NxStage System One(TM) at the Annual Dialysis Conference (ADC) 2012. NxStage will also host a special reception event, featuring celebrity kidney transplant patient and...
Certain treatment reminders in test results don't increase use of recommended medications or improve patients' health Highlights Certain treatment reminders meant to improve primary care physicians' prescribing habits for patients with chronic kidney disease (CKD) are ineffective. Nearly 20% of people over the age of 65 years have CKD, and primary care physicians care for the vast majority of them. Additional studies are needed to find ways to help improve...
Patients with chronic kidney disease who received the vitamin D compound paricalcitol for up to 48 weeks did not show improvement on measures of cardiac structure, function, or left ventricular mass, compared to patients who received placebo, according to a study in the February 15 issue of JAMA. "Although primarily recommended for improving bone health, treatment with vitamin D recently has been suggested for other conditions, including cardiovascular disease (CVD)," according to...
An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients, said the authors of a study in patients with chronic kidney disease (CKD). The researchers found that systolic blood pressure – the “upper number” in a blood pressure reading – was the key variable. Current guidelines call for CKD patients to maintain a systolic pressure of 130/80 or lower in order to prevent...
Drugs that treat anemia are critical for many who have kidney disease Highlights More than 20 million adults in the United States have chronic kidney disease. Drugs that treat red blood cell deficiencies are critical for maintaining many chronic kidney disease patients' health. Experts comment on newly released federal recommendations for these drugs. The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they...
TNF receptor levels in the blood warn of kidney problems for individuals with Type 1 and Type 2 diabetes Highlights High levels of TNF receptors in the blood increased diabetes patients' risk of developing kidney problems by three- to five-fold a decade later. Measuring blood levels of TNF receptors may help predict which patients' kidneys are in jeopardy, and targeting TNF receptors may help protect them. Half a million people in the U.S. have kidney failure and...
Upper GI bleeding common and serious in dialysis patients Highlights Bleeding in the upper gastrointestinal tract occurs more than 10 times as often in kidney failure patients than in individuals in the general population. Upper gastrointestinal bleeding causes serious health problems—and even early deaths—for many patients with kidney failure. More than 600,000 patients in the United States have kidney failure. Bleeding in the upper gastrointestinal (GI)...
